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ثنائية متالزمة العني الدماغية - مضاعفات نادرة ناجتة عن داء الفطرية 
املخاطية يف مريض عماين
تقرير حالة ومراجعة األدبيات
�صامية اجلابري، حممد العربي، اأحمد الهنائي، في�صل العزري
امللخ�ص: تعترب متالزمة العني الدماغية من احلالت غري ال�صائعة ن�صبيا. تزامن الثنائية يف وقت واحد، تعد اأقل �صيوعا وذكرت فقط يف 
%22 من جميع احلالت. يوجد العديد من الأعرا�ض ال�رسيرية، لكن يعترب فقدان الب�رس  واآلم  العني من اأكرثها �صيوعا. هذه املتالزمة 
حتدث عندما يكون هناك ان�صداد يف ال�رسيان ال�صباتي بن�صبة %90 اأو اأكرث، ومن املعروف جيدا اأنها ترتافق مع عدد من الأمرا�ض مبا يف 
ذلك مر�ض ال�صكري، ارتفاع �صغط الدم واأمرا�ض ال�رسايني التاجية والدماغية. يعد حدوث متالزمة العني الدماغية كم�صاعفات ناجتة عن 
داء الفطرية املخاطية من احلالت النادرة.  يف هذا التقرير نوثق حالة نادرة من ثنائية متالزمة العني الدماغية ناجتة عن ت�صيق ال�رسيان 
ال�صباتي ب�صبب م�صاعفات داء الفطرية املخاطية. بالإ�صافة  ي�صتعر�ض هذا التقرير الأدبيات الطبية املن�صورة عن هذه املتالزمة من حيث 
الأعرا�ض ال�رسيرية ، وطرق الت�صخي�ض املتبعة واخليارات العالجية.
مفتاح الكلمات: متالزمة العني الدماغية، داء الفطرية املخاطية، ت�صيق ال�رسيان ال�صباتي، ت�صوير نظام ال�رسيان ال�صباتي، تقرير حالة، عمان 
abstract: Ocular ischaemic syndrome (OIS) is a relatively uncommon condition. Simultaneous bilateral 
involvement is even less common and has been reported in only 22% of all cases of OIS. It has variable clinical 
presentations, of which visual loss and ocular pain are the most common. It is believed to occur when there is a 
90% or greater carotid artery obstruction. This syndrome is often associated with a number of systemic diseases 
including diabetes mellitus, hypertension, coronary artery disease, and cerebrovascular disease. Only occasionally 
has it been described as a complication of rhinocerebral mucormycosis. We report an unusual case of bilateral OIS 
secondary to bilateral internal carotid artery thrombosis as a complication of invasive rhinocerebral mucormycosis. 
In addition, a review of clinical presentation, diagnostic work-up and treatment options for OIS is provided.
Keywords: Ocular ischemic syndrome; Mucormycosis; Carotid stenosis; Carotid system imaging; Case report; 
Oman. 
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case report
Mucormycosis is the most invasive and rapidly progressive fungal infection in humans, of which 
rhino-orbito-cerebral involvement is a common 
manifestation.1 Affected individuals invariably 
have underlying disorders like diabetes mellitus, 
renal failure, liver cirrhosis, leukaemia, lymphoma, 
or other immunocompromised states.1,2,3 Ocular 
involvement in mucormycosis is usually in the 
form of orbital cellulitis. The pathway of spread 
begins with inoculation of the nasal mucosa with 
the mucor pathogen followed by invasion of the 
paranasal sinuses. The pathogen then moves to 
the inferior orbital fissure leading to thrombosis 
of regional blood vessels. This results in acute 
ocular symptoms of the eyelid, including oedema 
and chemosis. Extension of the infection into the 
orbital apex causes proptosis. Visual loss may 
develop secondary to invasion into the optic nerve 
or thrombosis of the retinal artery.1 Intracranial 
spread of the infection is believed to occur through 
the cribriform plate or orbital apex. In addition, 
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the organism spreads along the meninges, nerves, 
and vessels. Hyphae can erode through the 
vascular endothelium leading to thrombosis, brain 
infarction, and necrosis. Vascular thrombosis in this 
mechanism may involve cavernous sinuses or the 
carotid artery.2 Ocular ischaemic syndrome results 
from severe and chronic hypoperfusion to ocular 
structures commonly due to severe atherosclerosis 
of the carotid vascular system with insufficient 
collateral circulation. There are few case reports in 
the literature of carotid vascular system thrombosis 
in association with invasive mucormycosis with 
secondary ocular involvement and severe visual 
loss. Most of these patients had a direct orbital 
involvement with signs of orbital cellulitis.2,4 
In this article we report a case of rhinocerebral 
mucormycosis with no evidence of direct spread 
through the orbit. The patient developed cavernous 
sinuses and bilateral internal carotid artery 
thrombosis leading to bilateral OIS, which resulted 
in severe visual loss.
Case Report
In January 2010, a 57-year-old Omani woman 
who was a known diabetic and had been receiving 
treatment for hypertension for many years 
developed right cavernous sinus thrombosis. In 
May 2010, she  was diagnosed with chronic invasive 
rhinocerebral mucormycosis for which she was 
started on amphotericin and voriconazole and 
underwent multiple sinus debridement surgeries. In 
February 2011, she developed a right middle cerebral 
artery and anterior cerebral artery stroke and renal 
failure. She had a partial recovery with residual 
dysarthria for which she was treated with aspirin 
and clopidogrel. Amphotericin was substituted 
for caspofungin and posaconazole due to renal 
failure. During one of her recent admissions for 
another sinus debridement surgery, she complained 
of bilateral sudden visual loss associated with 
right eye pain. Her past ocular history revealed a 
bilateral cataract extraction with an intraocular lens 
 
Figure 1: (A&B) Color fundus photographs of the right and left eyes respectively, shows pale discs, attenuated retinal 
arteries, microaneurysms, no neovascularisation of discs or elsewhere and no macular oedema in both eyes. Scattered 
exudates were noted over the macula of the right eye. (C) Fundus fluorescein angiography (FFA) of the left eye at 07 
seconds shows delayed choroidal filling. (D) FFA of the left eye at 3:36 seconds shows widespread of retinal ischaemia 
and prominent staining of retinal arterioles.
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implantation, bilateral non-proliferative diabetic 
retinopathy, and diabetic macular oedema. Her right 
eye was treated with a focal laser. Her baseline visual 
acuity was 0.3 in the right eye and 0.8 in the left eye. 
An ophthalmic examination on the day of referral 
revealed no light perception in either eye. However, 
after one hour her perception improved to 0.2 in 
the right eye and 0.1 in the left eye at a distance of 
one metre. An anterior segment examination for 
both eyes (OU) was unremarkable except for mid-
dilated poorly reactive pupils and pseudophakia. 
Her intraocular pressure (IOP) OU was normal. 
There was no proptosis, and ocular motility was 
normal for OU. A dilated fundus examination 
revealed bilateral multiple microaneurysms; dot 
and blot retinal haemorrhages at the posterior pole 
and to some extent at the mid-periphery; pale optic 
discs, and attenuated retinal arteries. There was no 
neovascularisation of the disc or elsewhere, and 
there was no macular oedema OU [Figures 1a and 
b]. Fundus fluorescein angiography (FFA) revealed 
a bilateral delayed choroidal filling with evidence of 
widespread retinal ischaemia [Figures 1c and d].
A magnetic resonance imaging (MRI) scan 
showed diffuse inflammatory changes in the 
paranasal sinuses. There was a loss of the normal 
signal void within both internal carotid arteries at 
the level of the cavernous sinuses in keeping with 
thrombosis of the internal carotid arteries (ICAs). A 
MRI angiogram showed complete absence of flow in 
the ICAs [Figures 3a and b]. This was confirmed by 
conventional digital subtraction angiography (DSA) 
of the ICAs as well as by cerebral angiography, 
which revealed bilateral abrupt occlusion of the 
internal carotid arteries. However, there were good 
collaterals with opacification of the internal carotid 
arteries distal to cavernous sinuses through dural 
and meningeal collateral arteries [Figures 3a and 
b]. Electroretinograghy showed a decrease in the 
amplitude of both A- and B-waves. 
No neovascularisation of anterior or posterior 
segments were detected throughout the follow-
up period. However, the patient developed open 
angle glaucoma with poorly controlled IOP, optic 
nerve cupping with further deterioration in vision 
to light perception in the right eye, and no light 
perception in the left eye. In April 2012, she was 
still attending hospital follow-up visits to monitor 
her rhinocerebral mucormycosis for which oral 
posaconazole was prescribed. 
Discussion
The incidence of OIS is estimated to be 7.5 cases 
per million persons per year.5 This figure could be 
underestimating the true incidence, probably due to 
Figure 2: (A) Axial T2W magnetic resonance (MR) image through the cavernous sinus showing loss of normal 
signal void in the internal carotid arteries (arrow), in keeping with thrombus within the ICA. (B) A time-of-flight 
MR angiography reformat image shows absence of both internal carotid arteries. The middle cerebral arteries (white 
arrows), basilar artery are with in normal limits (yellow arrow).
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the overlap between OIS in its clinical presentation 
and other ocular vascular diseases such as retinal 
vein occlusions and diabetic retinopathy.5,6 The fact 
that atherosclerotic vascular disease is the major 
cause of OIS explains why it is twice as common in 
males and why it typically occurs at a mean age of 65 
years.5 This also contributes to the close association 
of OIS with vasculopathic conditions such as 
diabetes, hypertension, and hypercholesterolaemia, 
and the increased risk for OIS among patients 
with a previous history of stroke and myocardial 
infarction. Severe carotid artery occlusion by 
atherosclerosis with poor collateral circulation is 
evident in the majority of patients with OIS who 
present with the above risk factors. On the other 
hand, in a large randomised prospective study, 
around 26% of affected eyes with OIS were found 
to have no or mild ipsilateral carotid stenosis. This 
was explained by a possible vascular occlusion at 
the level of the aortic arch, and at the ophthalmic, 
central retinal, or ciliary arteries.7 
Other aetiological factors leading to OIS include 
giant cell arteritis, aortic arch syndrome, Takayasu 
arteritis, and hypercysteinemia.5–8,9 Moreover, there 
have been several reported cases in the literature 
of carotid artery thrombosis secondary to invasion 
with mucormycosis, making mucormycosis another 
risk factor for OIS.1–3
Our patient had multiple atherosclerotic risk 
factors in addition to mucormycosis, which might 
together have contributed to the ICA occlusion. 
Her initial visual presentation was probably due to 
transient embolisation of the central retinal artery, 
or its branches or vasospasm.5,4 Visual loss in OIS 
is the most common symptom and it could be 
transient, sudden, or, most commonly, gradual.10,11 
Ocular pain is the second most common symptom 
and it is a result of either an increase in intraocular 
pressure or ischaemia to the globe or ipsilateral 
dura.6 Our patient had ocular pain at presentation 
in the absence of neovascular glaucoma which 
might suggest ischaemia was the likely cause.
Anterior segment signs of ocular ischaemia 
include corneal oedema with Descemet’s folds, 
scleral melting, iris atrophy and neovascularisation, 
fixed semi-dilated or poorly reactive pupils, 
peripheral anterior synechia with angle closure, 
mild iritis, and cataracts. Among these signs, 
neovascularisation of the iris (NVI) is the most 
common (90%) and when seen at presentation it 
is an indicator of a poor prognosis.10 Our patient 
did not have iris atrophy or NVI; however, she 
had poorly reactive pupils, probably due to retinal 
ischaemia and/or ischaemic optic neuropathy or 
iris ischaemia.
Figure 3: (A) Lateral left carotid conventional angiogram demonstrating complete occlusion of the proximal left internal 
carotid artery (ICA) (white arrow). There is opacification of the supra-clinoid ICA (yellow arrow). (B) Lateral right 
carotid angiogram demonstrating similar findings as the left side.
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Generally, in OIS, intraocular pressure may be 
raised if fibrovascular tissue develops in the angle 
causing angle closure, or it may be normal or even 
low if aqueous production is reduced due to ciliary 
body ischaemia. Also, normal tension glaucoma 
is described as occurring in conjunction with OIS 
due to a chronic reduction of the retrobulbar blood 
flow.5 Our patient developed limited peripheral 
anterior synechiae (PAS) probably secondary to 
undetected fine angle neovascularisation, but the 
angles remained open. During subsequent follow-
up visits, our patient was found to have high 
intraocular pressure OU with optic nerve cupping 
due to uncontrolled open angle glaucoma probably 
not directly related to OIS. 
Posterior segment signs in OIS include 
attenuated retinal arteries; dilated but not tortuous 
retinal veins; mid-peripheral and posterior pole dot 
and blot retinal haemorrhages; microaneurysms; 
macular oedema; cherry red spots; cotton wool 
spots; anterior ischaemic optic neuropathy; 
neovascularisation of the disc or less commonly of 
the retina, and vitreous haemorrhage.5 Our patient 
had attenuated retinal arteries and pale optic discs, 
possibly due to anterior ischaemic optic neuropathy. 
This latter sign is seen in up to 18% of eyes affected 
by OIS.5 Anterior ischaemic optic neuropathy can 
result from chronic IOP elevation in the presence of 
compromised ocular perfusion.10
Diagnosis of OIS is made based on high 
clinical suspicion and confirmed by ancillary tests 
including FFA, indocyanine green angiography 
(ICG), electroretinograghy, carotid system studies. 
FFA is useful in OIS not only for diagnosis 
but also for planning treatment. If it reveals 
significant retinal ischaemia with the presence 
of retinal neovascularisation, then panretinal 
photocoagulation (PRP) laser treatment is 
indicated.10 The most specific angiographic sign 
in OIS is delayed or patchy choroidal filling, which 
is found in 60% of cases. A highly sensitive sign is 
prolonged retinal arteriovenous time (95%).5 Other 
angiographic signs are prolonged retinal circulation 
time, staining of retinal vessels (85%), well-
demarcated fluoresce in the dye edge, and retinal 
capillary non-perfusion.5
Computed tomography (CT) angiography 
and MRI angiography have gradually replaced the 
digital subtraction angiography (DSA) method 
for studying carotid occlusive disease with high 
sensitivity and specificity reaching 97% and 99%, 
respectively.5 
ICG typically shows prolonged choroidal 
filling.5 Moreover, electroretinograghy in OIS will 
typically show a decrease in the amplitude of both 
A- and B-waves reflecting ischaemia of both the 
outer and inner retinas.5,6 The aim of OIS treatment 
is to control anterior segment inflammation, ablate 
retinal ischaemia with PRP, and control neovascular 
glaucoma.5,10 Anterior segment inflammation is 
treated with regular topical steroids and long-acting 
cycloplegic agents to stabilise the blood-aqueous 
barrier. Our patient had no anterior segment 
inflammation.
PRP is generally recommended in cases of 
established retina ischaemia with presence of iris 
or angle neovascularisation.10 PRP can result in 
regression of anterior segment neovascularisation 
in only 36% of eyes.12 There is no role for PRP if no 
retinal ischaemia is found with anterior segment 
neovascularisation as the latter may result from 
uveal ischaemia alone.13 Our patient did not develop 
iris or angle neovascularisation; therefore, PRP was 
not required. Intravitreal injection of antivascular 
endothelial growth factor and steroids have been 
used in some eyes with OIS with NVI or macular 
oedema which resulted in reasonable regression of 
neovascularisation and improvement in macular 
oedema but no change in visual acuity.5,14 
In eyes with useful vision or that have 
potential for visual recovery and uncontrolled IOP, 
trabeculectomy with antimetabolites, or  aqueous 
shunt implants may be indicated. In painful 
blind eyes, cycloablation or even enucleation or 
evisceration are considered.10 
The management of OIS requires a 
multidisciplinary approach to assess and optimise 
treatment of underlying systemic conditions. The 
5-year mortality rate in OIS is around 40%, mostly 
due to cardiac disease.10 Risk of stroke is also 
significantly increased (4% per year in patients with 
OIS as compared to 0.49% per year in the control 
group).5
Carotid artery surgery, either endarterectomy 
or bypass surgery, may relieve OIS and also reduce 
the risk of stroke.10 Surgery has to be considered in 
cases of carotid artery stenosis and occlusion with 
atherosclerosis. 
In cases of carotid artery thrombosis, 
thrombolytic therapy may be considered along with 
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treatment of the underlying cause. Gelston et al. 
and Simmons et al. reported successful treatment 
of a diabetic child with rhino-orbital mucormycosis 
with orbital compromise and evidence of ipsilateral 
carotid artery and cavernous sinus thrombosis. 
The child was treated with systemic posaconazole, 
amphotericin B, granulocyte colony-stimulating 
factor, interferon gamma, and low-molecular 
weight heparin. She showed clinical improvement 
with partial recovery of her vision.2,4 
Conclusion
We presented a case of bilateral OIS which is one 
of the rare ocular complications of rhinocerebral 
mucormycosis. OIS has variable clinical 
presentations and can be masked by other ocular 
vascular conditions; therefore, it is probably 
underdiagnosed. Various ocular tests and carotid 
system studies are useful in diagnosis and planning 
treatment. The mainstay of treatment is IOP 
control, PRP if indicated, and medical treatment of 
underlying conditions. 
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